Patent · US Active

Formulations of 6-mercaptopurine

US9375403B2 · kind B2 · utility

2Cited by
31References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 25, 2015
Grant dateJun 28, 2016
Priority date
Expiry dateJun 25, 2035

Classification

  • Technology area (CPC B)Performing Operations; Transporting
  • CPC primaryB01J2/16
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides improved formulations of 6-mercaptopurine that exhibit better bioavailability and faster dissolution than previous formulations.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.